Our team shares an unwavering commitment to improving health outcomes for patients with cancer and a proven track record of accomplishment. Collectively, among the executive team, scientific advisory board, and board of directors, we’ve played a key role in generating meaningful advances across the spectrum of drug discovery and delivery:
- 200 small molecule drugs to the clinic
- 40 drugs approved and in clinical use today
![5 parallel pink lines winding through circle containing a photo of [X]. Two small orange circles surround the main photo.](/static/team-intro-img-8d7f359c852600322297ba97d736d9ef.png)
![5 parallel green lines winding through circle containing a photo of [X]. Two small blue circles surround the main photo.](/static/joining-our-team-2741a73d07f15614022e9bedeb718c1e.png)